Our in vitro studies further support that wildtype LOX-PP (Arg LOX-PP) inhibits LOX expression in an oral-tumor cell line, while mutant LOX-PP (Gln LOX-PP) has a reduced inhibitory effect. This evidence concerns the gene LOX and neoplasm.